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Dickkopf (DKK) proteins interact with low-density lipoprotein receptor-related protein 5/6 (LRP5/6) to 
modulate WNT signaling.  The interaction is mediated by a cysteine-rich domain (C2) in the DKK pro-
tein and ｹ-propeller domains (PD) of LRP5/6.  However,  the third member of the DKK family (DKK3) 
does not bind to LRP5/6.  To determine why DKK3 does not bind to the receptor domains,  we per-
formed a molecular modeling simulation study including homology modeling,  protein-protein docking 
and molecular dynamics (MD).  The computed aﬃnities (ΔGbinding) between the C2 and PD models were 
consistent with the previously reported experimental results.  The C2 model of DKK3 showed the low-
est aﬃnity for PD models.  Multiple sequence alignment of C2 domains revealed that the DKK3 genes 
have a unique 7-amino-acid insertion (L249-E255 in human DKK3) and P258 in a ﬁnger loop 1 (FL1).  
Interestingly,  the insertion sequence is evolutionally conserved.  MD simulations of high-aﬃnity com-
plex models of C2 and PD showed that FL1 directly interacts with the PD models and stabilizes the 
complex models.  We also built a 7-amino-acid-deletion/P258G mutant model of DKK3C2 and estimated 
its aﬃnities for the PD models.  The aﬃnity for human LRP5PD2 was increased by the substitution 
(ΔGbinding＝－48.9kcal/mol) and the aﬃnity was compatible with that of high-aﬃnity ligands.  The 
results suggested that the lack of aﬃnity between human DKK3 and human LRP5/6 results from:  
i) insertion of the 7 amino acids,  and ii) P258 in human DKK3.  The sequence diﬀerences thus suggest 
an explanation for this unique property of DKK3.
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he Dickkopf-3 (DKK3) protein was identiﬁed 
through the expression analysis of immortalized 
is also known as the REIC (reduced expression in 
immortalized cells) protein [1].  Expression of DKK3 
is epigenetically suppressed in various types of carci-
noma [2-13].  It has been revealed that DKK3 exerts 
explicit tumoricidal activity [14-18] and anti-tumor 
immune response [19].  DKK family genes (DKK1-4) 
encode a pair of cysteine-rich domains (C1 and C2).  
The amino acid sequences of the C1 domains of DKK1 
and DKK2 are 50ｵ identical and those of the C2 
domains are 70ｵ identical [20].  The sequence simi-
larity indicates that the C2 domain is more function-
ally important.  In fact,  the C2 domains of DKK1 and 
DKK2 have been shown to modulate WNT signaling 
[20].  It has also been shown that DKK4 weakly regu-
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lates the WNT signaling [21].  The C2 domains 
directly bind to low-density lipoprotein receptor-
related protein 5/6 (LRP5/6) for the regulation of 
WNT signaling [22-24].  However,  DKK3 completely 
lacks aﬃnity for LRP5/6 despite the presence of a C2 
domain [25].
　 LRP5 plays critical roles in osteogenesis,  includ-
ing bone mass control via regulation of WNT signal-
ing.  Genotyping analysis has revealed that mutations 
in LRP5 induce high bone-mass disorders [26-30] 
and osteoporosis pseudoglioma syndrome [31].  
Furthermore,  depletion of LRP6 causes fatal defects 
in mouse embryos [32].  Mutations in human LRP6 
(hLRP6) are associated with coronary artery disease 
and metabolic syndrome [33].  The binding regions of 
LRP5/6 for the C2 domain of DKK are located at the 
extracellular domain,  which is composed of four 
6-blade-type β-propeller units built by YWTD-EGF-
like segments.  The ﬁrst β-propeller domain (PD1) of 
LRP5/6 is thought to be responsible for recognition 
of DKK [34,  35].  Interestingly,  all of the mutations 
genetically linked to high bone-mass are located at the 
top surface of PD1 [30,  36,  37].  Recently,  the 
crystal structures of a complex formed between 
hDKK1C2 and hLRP6PD3/4 have been determined 
[38,  39].
　 In the present study,  we focused on the reason why 
DKK3 is unable to bind to LRP5/6.  We considered 
that proﬁles of the aﬃnities between C2 domains and 
PD would be helpful to answer this question.  Chen et 
al.  performed a protein-protein docking (PPD) simu-
lation using a molecular model of mouse DKK2C2 
(mDKK2C2) and hLRP6PDs [24].  In this study,  we 
performed molecular simulations to predict the com-
plex structures of C2 models in DKK proteins and PD 
models of LRP5/6 and to estimate their aﬃnities.
Materials and Methods
　 The computational procedure for modeling the 
protein complex and aﬃnity estimation is shown in 
Fig. 1.  The details for each step are described below.
　 Homology modeling and reﬁ nement. The 
structure of the C2 domain of mDKK2C2 has been 
determined by NMR spectroscopy [24] (PDB code:  
2JTK) and it was used as a model template for the C2 
domains.  The β-propeller domain of human low-den-
sity lipoprotein (LDL) receptor (PDB code: 1IJQ) 
[40] was utilized as a model template for LRP5/6.  
Amino acid sequences of the C2 and β-propeller domains 
of LRP5/6 were extracted from the H-Invitational 
Database release 5.3 [41,  42] and UniProtKB/
SwissProt [43].  The sequence IDs are listed in 
Table 1.  Modeller 9v6 [44,  45] was used for homol-
ogy modeling.  The homology model with the lowest 
DOPE score [46] was used for the subsequent steps.  
To reﬁne the homology models,  energy minimization 
and molecular dynamics (MD) simulations were per-
formed.  TIP3P water [47] was used for an explicit 
solvent model.  The force ﬁeld used was Amber ﬀ03.  
For energy minimization,  the steepest descent and 
conjugated gradient methods were applied.  The peri-
odic boundary condition [48] was used in the simu-
lated system to remove boundary eﬀects.  The cut-oﬀ 
distance of electrostatic interaction was 8Å.  The 
particle mesh Ewald [49] method was applied for 
computation of the energy of the Coulomb interaction.  
The integration time of an MD production run was 5ns 
and the time step was 0.002ps.  AMBER10 was used 
for energy minimization and MD simulation.
　 Prediction of complex and binding energy.
ZDOCK3.1 [50] was utilized for sampling complex 
models of C2 (as ligand) and PD (as receptor).  The 
RDOCK/CHARMM system [51] was used to select 
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Fig. 1　 Schemata of the prediction workﬂow used.  After the 
computation,  molecular dynamics (MD) simulations were performed 
on selected complex models to reﬁne the structures and to obtain 
dynamic structures.
the complex model with the highest aﬃnity.  ΔGbinding 
was used to estimate the aﬃnity of the complex model.  
ΔGbinding is formulated using a combination of theoreti-
cal and empirical measures for binding energy and 
reﬂects the aﬃnity of a protein-protein complex model.  
ΔGbinding is calculated by formula (1).
　　　　 ΔGbinding＝ΔGACE＋ß×ΔEelec　(1)
　ΔGACE denotes the atomic contact energy,  which was 
empirically determined based on X-ray structure 
analysis [52].  ß is a scaling factor for electrostatic 
energy and was set to 0.67 in this study.  In the com-
plex model sampling,  the sides and bottom of PD 
models were blocked because the top surface of the 
PD domain is responsible for DKK recognition [34].  
The contact surfaces were computed by MSMS [53].
　 Molecular dynamics simulation of the protein 
complex. MD simulation was performed to obtain 
the equilibrium state of the solvated complex model.  
First,  energy minimization was performed in a manner 
similar to that described above.  Next,  the system was 
gradually heated to 300K for 320ps.  After the heat-
ing,  the time step was changed to 0.002ps for the 
following 100ps and the thermodynamics ensemble 
was switched to NPT (isothermal-isobaric ensemble).  
Finally,  a production MD run was carried out for 5ns.  
The hydrogen bonds were counted if the averaged 
atomic distance was less than 4.0Å or the minimum 
distance was less than 3.0Å during the last 100ps.
　 Multiple sequence alignment. Multiple 
sequence alignment of the amino acid sequences of 
DKKC2 domains was generated with an online version 
of CLUSTALW [54] hosted by DDBJ [55].  The gap 
open penalty and extension penalty were 10.0 and 0.2,  
respectively.
Results
　 Dynamic structure of the C2 domains. In 
order to model C2 domains under an aqueous condi-
tion,  the molecular models were built by using a 
structural template of the solution structure of the 
mouse homolog [10] and reﬁned by MD simulation 
using explicit solvent.  Fig.  2 shows the dynamic 
structure of C2 models obtained in the MD simulation 
using an explicit solvent.  The sequence identities (ｵ
ID) between the target and the model templates are 
shown in Table 1A.  The C2 domains have 2 separated 
ﬁnger loops (FL1 and FL2).  FL1 and FL2 are indi-
cated by arrows in Fig.  2A,  D,  G and J.  The 
dynamic structures show that FL1 and FL2 are more 
ﬂexible than other parts of the C2 models.  The root 
mean square displacement (RMSD) from the starting 
structure (Fig.  2B,  E,  H and K) shows that FL1 and 
FL2 in the models were equilibrated around 4ns.  The 
atomic ﬂuctuations (Fig.  2C,  F,  I and L) show that 
the motion of FL1 in hDKK2C2 (T215-Q229) was 
greater than that in other regions.  This result is 
consistent with the results of NMR spectroscopy of 
mDKK2C2 [24].  FL1 of hDKK3C2 was longer than 
those of other C2 models due to a conserved 7-amino-
acid insertion (LDLITWE) unique to DKK3 (Fig.  3).  
Hence,  FL1 in DKK3C2 shows higher ﬂexibility 
because of the unique insertion.  FL1 of hDKK3 and 
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Table 1　 Data sources for homology modeling.  (A) The 
sequences IDs of human and mouse DKK1/2/3/4.  (B) The 
sequence IDs of human and mouse LRP5/6.  The regions listed are 
the targets for homology modeling.  The %ID with the template 
(2JTK for DKKC2 and 1IJQ for LRP5/6PDs) and DOPE scores are 
also listed.
A Seq. ID Modeled Region %ID＊ DOPE score
hDKK1C2 HIP000077490 K177-H266 65.9 －5158.9
hDKK2C2 HIP000022690 K171-I259 97.7 －5273.0
hDKK3C2 HIP000089868 K197-P286 31.3 －5802.9
hDKK4C2 HIP000109794 Q135-L224 56.1 －5048.8
mDKK1C2 O54908 K183-H272 63.2 －5032.9
mDKK3C2 Q9QUN9 Q197-P286 32.4 －5518.5
mDKK4C2 Q8VEJ3 S134-I221 55.4 －4995.3
＊Sequence identity with template (PDB code: 2JTK)
B Seq. ID Modeled Region %ID＊＊ DOPE score
hLRP5PD1
HIP000044088
P33-A340 35.1 －31602.0
hLRP5PD2 E342-E644 33.4 －31680.1
hLRP5PD3 V642-T945 28.8 －32787.0
hLRP5PD4 P943-P1257 23.8 －31993.3
hLRP6PD1
HIP000054962
P21-D325 34.7 －31960.5
hLRP6PD2 R340-P630 31.1 －29414.8
hLRP6PD3 P630-A931 33.0 －31929.8
hLRP6PD4 P932-E1245 25.3 －33624.8
mLRP5PD1
Q91VN0
F36-A339 34.0 －30773.3
mLRP5PD2 E341-P642 32.9 －31265.1
mLRP5PD3 P642-P942 30.2 －32532
mLRP5PD4 S944-E1254 23.0 －31866.1
mLRP6PD1
O88572
P21-D325 35.0 －32098.1
mLRP6PD2 R340-P630 30.1 －29716.7
mLRP6PD3 P630-A931 33.3 －31825.9
mLRP6PD4 P932-E1245 24.5 －32742.3
＊＊Sequence identity with template (PDB code: 1IJQ)
that of hDKK4 were twisted (Fig.  2G and J).  It 
should be noted that the C2 domains in hDKK3 and 
hDKK4 contain a proline residue (P258 in hDKK3 and 
P188 in hDKK4) at FL1 (see the alignment in Fig.  3).  
The proline residue is able to restrict conformation of 
the main chain due to its rigid cyclic structure.  Hence,  
we speculated that the twist of the loop is caused by 
the proline residue in hDKK3 and hDKK4 and that the 
conformation inﬂuences the aﬃnity for LRP5/6.  In 
fact,  the agonistic eﬀect of DKK4 on WNT signaling 
has been reported to be marginal compared with the 
agonistic eﬀects of DKK1 and DKK2 [21].  As 
described above,  DKK3 does not bind to LRP5/6.  
Therefore,  it is thought that the lower aﬃnity of 
DKK3 and DKK4 to LRP5/6 is due to the twisted 
conformation in FL1.
　 Dynamic structures of molecular models of 
the β-propeller domains in LRP5/6. The 
sequence alignments of the template (PDB code:  
1IJQ) and LRP5/6PDs show that the sequence identi-
ties ranged from 24ｵ to 35ｵ (Table 1B).  In the 
homology modeling,  3 intermolecular disulﬁde bonds 
in the EGF-like domain of PD models were con-
structed on the basis of the model template.  The 
computed dynamic structures of hLRP5PD1 to PD4 
are depicted in Fig.  4A,  C,  E,  and G.  According to 
the atomic ﬂuctuations in the equilibrium state (Fig.  
4B,  D,  F,  and H),  the conformation was rigidly 
maintained in all of the PD models except for the 
EGF-like domains.  Although several N-linked glyco-
sylation sites were predicted on β-propeller domains 
of hLRP5/6,  all of the glycosides were omitted in the 
molecular models.  Therefore,  the simulation results 
indicated that glycosylation is not important for the 
stability of β-propeller domains.  In the dynamic struc-
tures of the PD1,  PD2 and PD3 models of hLRP5,  
the atomic ﬂuctuations of EGF-like domains were 
greater than those of β-propeller domains (Fig.  4B,  
D and F).  According to their dynamic structures 
(Fig.  4A,  C and E),  the overall structures of EGF-
like domains were not disordered.  The ﬂexibility of 
the EGF-like domains seemed to be restricted by the 
disulﬁde bonds in their interiors.  These dynamic 
properties were also observed in the MD simulation 
for PD models of hLRP6 and the same series of 
mouse models (data not shown).  The ﬁnal structures 
of PD models in MD simulations were used as recep-
tors in the following PPD simulation.
　 Prediction of complex structures and aﬃ  ni-
ties of DKK ligands and receptors. The aﬃnity 
proﬁles of the predicted complexes are shown in 
Table 2.  Based on the proﬁle of the human model 
series (Table 2A),  the complex model with the highest 
aﬃnity was hDKK1C2-hLRP6PD1 (ΔGbinding＝－56.6 
kcal/mol).  This is consistent with the result of an 
experimental study showing that the C2 domain of 
DKK1 is directly bound to PD1 of LRP6 [56].  In the 
complex model of hDKK1C2-hLRP6PD1,  51 hydro-
gen bonds were detected.  The contact surface area 
was 3,960Å2.  According to the statistics on 75 pro-
tein-protein complexes,  the contact surface ranges 
from 1,150 to 4,660Å2 [57].  Hence,  the complex is 
cooperatively maintained by the hydrogen bond net-
work (HBN) and the broad contact surface.  Binnerts 
et al.  suggested that Ser243 in PD1 of hLRP6 was 
important for binding to DKK1 [56].  In our predicted 
complex model,  the hydroxyl group of Ser243 was 
involved in hydrogen bonds with atoms in Cys201 of 
hDKK1.  The atomic distances of Cys201O-Ser243OG 
and Cys201N-Ser243OG were 2.67Å and 3.23Å,  
respectively.  This means that Cys201 and Ser243 are 
associated by 2 hydrogen bonds.  The computed 
ΔGbinding of hDKK1C2-hLRP6PD3 was －48.0kcal/mol.  
The crystal structure of the complex has been inde-
pendently determined by 2 groups [38,  39].  In both 
crystal structures (PDB code: 3S8V and 3S2K),  one 
engineered protein from hDKK1C2 and 2 proteins 
from hLRP6PD3/4 are included in a unit cell of the 
crystal.  Hence,  it has been observed in these crystal-
lographic studies that one hDDK1 protein makes 2 
diﬀerent contacts with the hLRP6 proteins.  It is 
natural to consider that one of the hDDK1-hLRP6 
contacts observed in the crystal structure is biologi-
cally relevant but the other is accidentally formed in 
the process of protein crystallization.  Our predicted 
binding mode of hDKK1C2-hLRP6PD3 showed a 
signiﬁcant structural similarity with one of the con-
tacts observed in the crystals.  The superimposed 
structures between the predicted complex model and 
crystal structure are depicted in Fig.  5.  The root 
mean square (RMS) deviations for Cα of our predicted 
structure against 3S8V and 3S2K were 4.18Å and 
3.96Å,  respectively.  The other contact observed in 
the crystals was dissimilar with our predicted binding 
mode (RMS deviation for Cαｧ8Å).  The good accor-
dance with the experimental results suggests that our 
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prediction approach is reasonable.
　 It should be noted that ΔGbinding of the hDKK3C2 
model and PD models of LRP5 or 6 ranked the worst 
among the DKK models.  For example,  the computed 
aﬃnity of the hDKK3C2 model and hLRP5PD2 model 
(ΔGbinding＝－31.2kcal/mol) was the lowest among the 
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Fig. 2　 Computational results of MD simulation for the modeled C2 domains of human DKK proteins.  A,  D,  G and J are dynamic 
structures that are represented by an overlap of snapshots from the MD simulations.  The ﬂexible loops (FL) in each structure are indicated 
by arrows.  The colors in the structures indicate the duration of the snapshot.  Green: 1 ns; blue: 2 ns; orange: 3 ns; pink: 4 
ns; yellow: 5 ns.  B,  E,  H and K shown the time-course development of RMSD values in the MD simulations.  The plots colored in red,  
blue and green indicate the full structures of C2 models,  FL1 and FL2,  respectively.  C,  F,  I and L show the atomic ﬂuctuations of the 
peptide backbone by residue in MD simulations.  The regions of the FL loops are indicated by lines.  The graphics of the protein-protein 
complex models are depicted using Discovery Studio 2.5 (http://accelrys.com/events/webinars/discovery-studio-25/).
C2 complexes with hLRP5PD2.  This result means 
that hDKK3 has the lowest aﬃnity among the DKK 
proteins.  This tendency was also observed in the aﬃn-
ity proﬁles of mouse models (Table 2B).  Judging from 
the above,  hDKK3 and mDKK3 have less aﬃnity for 
the LRP receptors,  which is consistent with the 
experimental results.  Fig.  6 shows the binding modes 
found in the complex model of C2 and hLRP5PD2.  
Although the binding modes were dissimilar,  FL1 and 
FL2 in the C2 models of DKK1/2/4 are in direct 
contact with the top of the β-propeller domain.  
According to the crystal structures of hDKK1C2 and 
hLRP6PD3,  FL1 of hDKK1C2 was directly attached 
to the top surface of the PD domain [38,  39].  This 
also supports our results in the complex prediction.  In 
contrast,  FL1 of the hDKK3C2 model was not in 
contact with the hLRP5PD2 model.  This unusual 
binding mode may result from the additional 7-amino-
acid sequence unique to DKK3.
　 Dynamic properties of the interaction in 
high-aﬃ  nity complexes
　 1. Contribution of FL1 and FL2 in the 
hDKK1C2ﾝLRP6PD1 complex model. According 
to the aﬃnity proﬁle,  the hDKK1C2-hLRP6PD1 
complex model has the highest aﬃnity among the 
human models (ΔGbinding＝－56.6kcal/mol).  To eluci-
date the dynamic properties and persistence of HBN 
found in the complex model,  MD simulation was per-
formed.  Fig.  7A shows the dynamic structure of 
hDKK1C2 in the complex model in the equilibrium 
state.  According to the dynamic structure,  FL1 
maintained tight contact with the top surface of the 
hLRP6PD1 model.  Fig.  7B shows the RMSD during 
the MD simulation.  The RMSD of the complex model 
shows that the system was equilibrated suﬃciently.  It 
also shows that the dynamics of the receptor-free 
model of hDKK1C2 compared well with that of the 
complex.  This means that hDKK1C2 is dramatically 
stabilized by the association with hLRP6PD1.  Fig.  
7C shows the atomic ﬂuctuations of residues in the 
PD-bound and unbound hDKK1C2 models.  The atomic 
motions of hDKK1C2 in the complex were smaller in 
all of the residues.  This also indicates that the recep-
tor binding enhances the stability of the C2 domain.  In 
particular,  3 separate regions consisting of C195- 
H204,  S207-H224 and R236-Q248 in the hDKK1C2 
model were strongly stabilized by the receptor bind-
ing.  It is interesting to note that most parts of the 
stabilized regions were outside of FL1 (T221-Q235) 
and FL2 (I247-L260) in hDKK1C2.  This suggests 
that not only FL1 and FL2 but also other regions 
contribute to formation of the complex.  Indeed,  as 
shown in Table 3,  the HBN between hDKK1C2 and 
hLRP6/5PD1 was observed not only at the FL1 and 
FL2 but also at the regions outside of FL1 and FL2.  
Sixty-six hydrogen bonds were found in the equili-
brated state of the complex model.  Twenty-four of 
those hydrogen bonds were thought to persist in the 
equilibrated state because the averages of their atomic 
distances over the preceding 100ps were less than 
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A B
Fig. 3　 A,  Multiple alignments of the C2 domains in human and mouse DKK proteins.  The conserved amino acid residues are repre-
sented by the black letters.  The non-conserved residues that maintain a similar polar property are shown with a gray background.  The 
amino acid insertion unique to DKK3 and Pro258 and that observed only in DKK3 are indicated by arrows; B,   Amino acid sequences of 
the C2 domains in human DKK proteins.
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Fig. 4　 Dynamic structures of the modeled β-propeller domains (PD) in hLRP5 proteins.  A,  C,  E and G are dynamic structures of 
PD1,  2,  3 and 4,  respectively.  Top (right) and side (left) views are shown.  The snapshot structures are colored in the same manner as 
those in Fig. 2.  B,  D,  F and H are atomic ﬂuctuations of the backbone by residue in MD simulations.
A B
Fig. 5　 A,  Overlapped structure of crystal-
lized [light green,  PDB code: 3S8V (Cheng 
et al. 2011)] and our predicted structure of 
hDKK1C2-hLRP6PD3 (yellow).  The RMS 
deviation between the structures was 
3.96Å; B,  Overlapped structure of crystal-
lized [purple,  PDB code: 3S2K (Ahn et al. 
2011)] and our predicted complex of 
hDKK1C2-hLRP6PD3 (yellow).  The RMS 
deviation between the structures was 4.18Å.
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Fig. 7　 A,  Complex model of hDKK1C2-
hLRP6PD1.  The dynamic structure of the 
hDKK1C2 model,  which was obtained by MD 
simulation,  is represented on the left.  The 
dynamic structure is colored in the same man-
ner as that in Fig. 2.  A 90° rotated view of the 
complex model is also depicted to show the 
receptor recognition position of hDKK1C2 
(right); B,  Time-course development of the 
RMSD values in MD simulations of the com-
plex model and free hDKK1C2.  The plots in 
green,  red and gray indicate hDKK1C2,  hLR-
P6PD1 in the complex model,  and free 
hDKK1C2,  respectively; C,  Atomic ﬂuctua-
tion of the peptide backbone in hDKK1C2.  
The plots in green and gray indicate 
hDKK1C2 in the complex and free form,  
respectively.
Fig. 6　 Predicted complex models of the C2 domains 
in hDKKs and hLRP5PD2 predicted by protein-protein 
docking simulations.
4.0Å.
　 2. Signiﬁcance of FL1 in the hDKK1C2ﾝ
LRP5PD1 model. In biochemical experiments on 
WNT signaling,  hDKK1 is frequently used as an 
antagonist for hLRP5 due to its eﬀective inhibitory 
response.  The interaction between hDKK1 and hLRP5 
has been characterized in experimental studies using 
mutation analyses.  Several mutations in hLRP5 were 
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A ΔGbinding hDKK1C2 hDKK2C2 hDKK3C2 hDKK4C2
hLRP5PD1 －47.70 －50.56 －29.33 －40.21
hLRP5PD2 －56.02 －55.25 －31.22 －47.95
hLRP5PD3 －42.90 －36.42 －28.64 －43.43
hLRP5PD4 －29.07 －30.99 －24.97 －19.77
hLRP6PD1 －56.57 －34.02 －27.63 －44.89
hLRP6PD2 －44.54 －36.72 －32.41 －38.42
hLRP6PD3 －48.57 －31.43 －22.89 －21.15
hLRP6PD4 －28.20 －26.95 －31.51 －25.96
Table 2　 Aﬃnity proﬁle of the complex models consisting of human (A) or mouse (B) C2 domains of DKK ligand and PD domains of 
LRP5 and 6.  The values shown are in kcal/mol.
B ΔGbinding mDKK1C2 mDKK2C2 mDKK3C2 mDKK4C2
mLRP5PD1 －47.75 －51.38 －37.07 －70.50
mLRP5PD2 －46.79 －45.76 －44.03 －47.19
mLRP5PD3 －33.26 －34.48 －25.38 －37.24
mLRP5PD4 －40.46 －30.57 －35.43 －35.06
mLRP6PD1 －42.99 －36.36 －26.29 －50.79
mLRP6PD2 －43.48 －56.72 －39.09 －56.43
mLRP6PD3 －36.90 －35.66 －29.59 －33.09
mLRP6PD4 －34.02 －27.66 －34.37 －23.83
Unit is kcal/mol.
A hDKK1C2-hLRP6PD1 Average S.D. Minimum Maximum
H180N-T328O 2.25 0.01 2.11 2.40
E232O-R29NH1 2.85 0.02 2.57 3.76
H223NE2-E115OE1 2.87 0.02 2.60 3.48
K222NZ-ASP98OD1 2.91 0.04 2.56 4.03
K222NZ-S96O 2.99 0.04 2.60 4.02
R224O-R29NH1 3.05 0.13 2.64 4.70
S244OG-Q139NE2 3.10 0.09 2.69 4.70
E241OE2-K202NZ 3.11 0.21 2.58 4.94
R203NE-I265O 3.18 0.07 2.62 4.32
E241OE1-K202NZ 3.18 0.27 2.60 5.11
K222NZ-P97O 3.18 0.13 2.54 4.78
K222NZ-D98OD2 3.26 0.22 2.64 4.91
H266NE2-W157O 3.27 0.15 2.66 5.38
C201O-H245NE2 3.35 0.22 2.64 5.40
K249NZ-E115O 3.43 0.71 2.60 7.21
K222NZ-S96OG 3.44 0.12 2.66 4.49
Q235OE1-S267N 3.52 0.26 2.69 5.65
S244OG-Q139OE1 3.57 0.22 2.41 4.68
K208NZ-T244O 3.58 0.34 2.60 5.23
Y238OH-A201O 3.68 0.42 2.58 6.04
C245N-W157NE1 3.70 0.11 2.94 4.67
A202O-H245NE2 3.75 0.13 2.86 5.23
R224O-R29NH2 3.77 0.23 2.82 5.22
R203NH2-I265O 3.79 0.17 2.79 5.05
R203NH2-D264O 3.86 0.75 2.65 6.85
H180N-A327O 3.87 0.17 3.05 5.26
Unit is Å.
B hDKK1C2-hLRP5PD1 Average S.D. Minimum Maximum
K222NZ-E128OE2 2.86 0.03 2.58 3.62
R203NH2-Y195O 2.91 0.02 2.62 3.40
S207O-Y195OH 2.97 0.07 2.53 4.44
S228O-S280N 3.06 0.10 2.64 4.90
K222NZ-E128OE1 3.14 0.14 2.54 4.34
L231O-W255NE1 3.23 0.13 2.61 4.67
R203NH1-W170O 3.28 0.15 2.64 4.53
W206NE1-K215O 3.42 0.62 2.63 7.90
S207N-Y195OH 3.46 0.06 2.86 4.97
H229O-W255NE1 3.52 0.25 2.69 5.94
R203NH1-Y195O 3.57 0.33 2.68 5.27
H204O-Y195OH 3.61 0.11 2.75 5.15
H204N-Y195OH 3.62 0.11 2.89 5.73
F205O-Y195OH 3.63 0.14 2.88 5.40
R203NE-Y195OH 3.80 0.12 2.70 5.06
R203NH2-W170O 3.86 0.21 2.81 5.18
K222NZ-S109OG 3.87 0.25 2.87 6.73
H229O-S280N 3.92 0.16 2.67 5.31
S228O-R258NE 3.92 0.24 2.84 5.36
R203NH1-G171O 3.93 0.34 2.75 6.00
G230N-S280OG 3.94 0.09 3.20 5.13
A203NH2-W196NE1 3.99 0.18 3.20 6.20
Unit is Å.
Table 3　 The stable hydrogen bonds observed in the equilibrium state of dynamic structures of the complex models,  hDKK1C2-hLR-
P6PD1 (A) and hDKK1C2-hLRP5PD1 (B).  The averaged atomic distances and their standard deviation (S.D.) are shown along with the 
min/max distances observed during the last 100 ps of MD simulation on the complex models.  The values shown are in Å.
detected on the ﬁrst propeller domain of hLRP5 [28,  
30,  37].  The mutations were reported to reduce the 
aﬃnity for DKK1.  In order to determine the protein-
protein interactions contributing to the aﬃnity,  MD 
simulation of the hDKK1C2-hLRP5PD1 complex model 
was performed.  Similar to that of the hDKK1C2-
hLRP6PD1 model,  the molecular motion of the 
hDKK1C2 model was stabilized by binding to the 
hLRP5PD1 model (Fig.  8C).  The diﬀerence in the 
molecular motion of hDKK1C2 between the complex 
model with hLRP5PD1 and that with hLRP6PD1 was 
explained by comparing the binding mode and contact 
surface areas as follows.  In the complex model of 
hDKK1C2-hLRP6PD1,  FL1 and FL2 of hDKK1C2 
are in contact with the top surface of hLRP6PD1 
(Fig.  7A).  In the hDKK1C2-hLRP5PD1 model,  only 
FL1 attaches to hLRP5PD1 (Fig.  8A).  The contact 
surface areas of the hDKK1C2-hLRP6PD1 and 
hDKK1C2-hLRP5PD1 complex models were 3,960Å2 
and 2,627Å2,  respectively.  This means that FL1 is 
essential for binding to the PD domain and FL2 
assists in further stabilization of the protein complex.
　 The total number of stable hydrogen bonds 
observed in the equilibrium state of the complex model 
was 39.  This means that the complex model is stabi-
lized by HBN.  FL1 in DKK1C2 was responsible for 
33 hydrogen bonds in the complex model.  This means 
that more than half of the intermolecular hydrogen 
bonds in the complex model were produced by FL1.  
Hence,  it can be concluded that the hydrogen bonds 
provided by FL1 signiﬁcantly contribute to the inter-
action of hDKK1C2 and hLRP5PD1 (Table 3B).  
Although the contact interface of the complex model is 
relatively narrow,  the HBN eﬀectively stabilized the 
whole structure of the complex.  In addition,  a number 
of weak hydrogen bonds also contributed to the stabi-
lization of the complex (Table 4B).  The inhibitory 
level in WNT signaling by the DKK ligand is consid-
ered to be correlated with the stability of interaction 
between the C2 domain and PD domain.
　 Insertions/substitutions unique to DKK3 
and their inﬂ uence on the binding aﬃ  nity to 
LRP5. It is important to address the reason why 
DKK3 does not bind to PD domains.  As previously 
mentioned,  a conserved insertion (LDLITWE),  which 
is unique to both human and mouse DKK3C2,  was 
found in the multiple sequence alignment (Fig.  3).  In 
the homology models of DKK3C2,  the conserved 
regions were found in the FL1 region.  MD simulation 
of the complex model of hDKK1C2-hLRP5PD1 
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Fig. 8　 A,  The complex model of 
hDKK1C2-hLRP5PD1 ; B,  Time-course 
development of the RMSD values in the MD 
simulations.  The plots in green,  red and gray 
indicate hDKK1C2,  hLRP5PD1 in the complex 
model,  and free hDKK1C2 model,  
respectively; C,  Atomic ﬂuctuation of the 
peptide backbone in the hDKK1C2 model.  
The plots in green and gray indicate hDKK1C2 
models in the complex and free form,  respec-
tively.
revealed that FL1 is responsible for intermolecular 
HBN.  Judging from the ﬁndings above,  we speculated 
that the conserved insertion in DKK3 impairs the 
interaction with LRP5/6.  To conﬁrm our hypothesis,  
we built an additional model of hDKK3C2 that lacks 
the unique insertion (hDKK3C2Δ).  Since the same 
template (PDB: 2JTK) was employed for homology 
modeling of hDKK1C2 and hDKK3C2Δ,  there was no 
marked diﬀerence in modeling structure between them 
except for the FL1 region.  5-ns MD simulation of the 
hDKK3C2Δ model was performed to reﬁne the homol-
ogy model.  The ﬁnal structure was used for docking 
simulation of hDKK3C2Δ to PD models of hLRP5.  
Among the binding poses generated by the docking 
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A hDKK1C2-hLRP6PD1 Average S.D. Min. Max.
Y238OH-P225O 4.05 0.97 2.57 7.01
R224N-R29NH1 4.08 0.12 3.05 5.41
Q235OE1-S267OG 4.09 0.17 3.08 5.34
K249NZ-N117OD1 4.14 1.01 2.58 7.36
S192N-S243O 4.17 0.14 3.07 5.31
R203NH1-I265O 4.22 0.15 2.93 5.65
H266ND1-E159N 4.25 0.53 2.81 6.15
R203NH1-F266N 4.27 0.26 3.10 6.17
L231O-D30OD2 4.42 0.26 3.17 5.92
L231O-D30OD1 4.43 0.53 2.98 7.01
C245O-W157NE1 4.48 0.36 3.20 5.97
H261NE2-E115OE1 4.48 0.14 2.75 5.53
H266NE2-G158O 4.49 0.44 2.95 6.51
R246NE-Q139NE2 4.52 0.31 3.09 6.22
K222O-R29NH1 4.62 0.26 2.95 6.25
R246NE-Q139OE1 4.64 0.63 2.95 7.11
K222NZ-E115OE1 4.68 0.15 2.82 5.62
S192OG-S243OG 4.70 0.69 2.55 6.86
R203NE-D264O 4.91 0.62 3.12 7.45
R246NH2-E136OE1 4.91 3.00 2.63 11.23
R246NH2-N117OD1 5.10 2.93 2.68 9.12
G240O-K202NZ 5.10 0.25 2.66 6.69
R246NH2-N117ND2 5.20 2.44 2.90 8.54
R246NH1-Q139NE2 5.23 1.50 2.94 8.12
R246NH2-E136O 5.28 1.16 2.69 7.99
K249NZ-T116O 5.42 0.86 3.03 7.99
R203NH2-D264OD1 5.43 0.66 2.75 7.86
K226NZ-E51OE1 5.46 5.23 2.60 12.55
K222NZ-E115OE2 5.56 0.19 2.89 6.73
K249NZ-E136OE1 5.60 3.21 2.60 10.34
K226NZ-E51OE2 5.76 4.12 2.54 11.58
K208NZ-S246OG 5.77 0.44 3.10 7.61
R246NH1-E136O 5.80 0.76 2.85 8.02
R246NH2-E136OE2 5.81 1.78 2.70 10.06
R246NH2-Q139OE1 6.12 1.48 3.10 8.71
R246NH1-E136OE1 6.18 2.77 2.69 11.63
R259NH2-VAL90O 6.37 1.71 3.19 9.26
K226NZ-S71OG 6.79 4.71 2.74 13.49
R259NH1-VAL90O 7.02 2.29 3.17 9.45
K208NZ-D264OD1 7.25 4.12 3.18 12.03
K208NZ-D264OD2 7.44 2.71 3.16 11.35
K249NZ-VAL91O 7.60 2.31 3.06 11.41
B hDKK1C2-hLRP5PD1 Average S.D. Min. Max.
G230O-W255NE1 4.17 0.47 2.81 6.18
S228O-S280OG 4.20 0.17 3.10 6.15
F205N-Y195OH 4.25 0.16 3.14 6.18
H229NE2-Q256OE1 4.33 1.42 2.61 7.97
K226NZ-D64OD2 4.43 1.89 2.60 8.13
S228O-R258NH2 4.43 0.44 2.75 6.42
H229NE2-Q256O 4.45 1.96 2.79 8.77
S228OG-Y279OH 4.60 0.48 3.12 7.32
H229NE2-W255O 4.63 0.49 2.84 7.04
K226NZ-D64OD1 4.99 2.44 2.55 8.61
K208NZ-E172OE2 5.21 3.23 2.60 9.25
K208NZ-E172OE1 5.25 2.67 2.63 9.08
Q235OE1-Y195OH 5.46 0.48 2.94 7.53
G227O-Y279OH 5.68 3.39 2.87 10.46
K226NZ-E63OE2 6.63 3.42 2.84 10.93
K226NZ-E63OE1 7.06 2.55 2.63 11.51
K226NZ-Y279OH 8.02 5.17 2.80 13.83
G230O-W255NE1 4.17 0.47 2.81 6.18
Unit is Å.
Table 4　 The weak hydrogen bonds observed in the equilibrium state.  The averaged atomic distances,  and their standard deviation 
(S.D.) are shown along with the min/max distances observed in MD simulation on the complex models of hDKK1C2-hLRP6PD1 (A) and 
hDKK1C2-hLRP5PD1 (B).  The values shown are in Å.
simulation,  the complex model was selected base on 
the predicted binding aﬃnity and the resemblance to 
the hDKK1C2-hLRP5PD1 complex structure.  This 
enabled us to draw an adequate comparison between 
hDKK1C2 and hDKK3C2Δ.  ΔGbinding was computed in 
the same manner.  ΔGbinding values are shown in Table 
5.  Among the corresponding complexes,  ΔGbinding val-
ues of hDKK3C2Δ were lower than those of hDKK3C2 
(Table 2A).  This means that the aﬃnities of 
hDKK3C2Δ to hLRP5 will be slightly stronger than 
those of the wild-type hDKK3.  In particular,  ΔGbinding 
values of hDKK3C2Δ-hLRP5PD1 model (－40.6 
kcal/mol) and hDKK3C2Δ-hLRP5PD2 model (－39.8 
kcal/mol) imply that the aﬃnities were moderately 
increased by deletion of the conserved region.
　 Additionally,  we focused on P258 of hDKK3,  
which is adjacent to the C-terminal end of the con-
served insertion,  because P258 has a potential role in 
restriction of the FL1 conformation and thus a poten-
tial eﬀect on the binding aﬃnity for the receptors.  A 
P258G mutation model of hDKK3C2Δ (hDKK3C2Δ
P258G) was built in the same manner as used for the 
modeling procedure.  FL1 in hDKK3C2ΔP258G was 
untwisted.  Then hDKK3C2ΔP258G was docked to the 
PD models of hLRP5.  The results of the aﬃnity 
estimation are shown in Table 5.  It should be noted 
that ΔGbinding of the hDKK3C2ΔP258G model to the 
hLRP5PD2 model was －48.9kcal/mol.  This result 
indicates that hDKK3C2ΔP258G had suﬃciently high 
aﬃnity to bind to the receptor,  because the ΔGbinding 
values indicated similar levels of aﬃnity between the 
hDKK1C2-hLRP5PD1 model (－47.7kcal/mol) and 
hDKK1C2-hLRP6PD3 model (－48.0kcal/mol).  The 
above ﬁndings support our hypothesis.
　 As for FL2,  the amino acid sequence was not 
conserved and a large variation was seen among the 
DKK family members (Fig . 3).  The hydrogen bond 
analysis in Table 3 shows that no stable hydrogen bond 
from FL2 was observed in either the complex models 
of hDKK1C2-hLRP6PD1 or hDKK1C2-hLRP5PD1.  
Accordingly,  we considered that the FL2 region 
scarcely contributes to binding of the DKK2 protein 
to the β-propeller domains of LRP5/6.  In this work,  
we mainly focused on the FL1 region and no supple-
mentary computational analysis was performed for FL2.
Discussion
　 A series of molecular modelings including PPD 
simulations reproduced the following 4 key experi-
mental observations: i) both DKK1 and DKK2 are 
ligands with high aﬃnity to LRP5/6,  ii) DKK4 also 
binds to the receptor,  but the aﬃnity is weaker than 
those of DKK1 and DKK2,  iii) the binding modes 
found in the X-ray structures of hDKK1C2-hLR-
P6PD3 (PDB code: 3S2K,  3S8V) show the impor-
tance of FL1 for interaction of the complex; and iv) 
DKK3 does not bind to the receptors.  Furthermore,  
the binding modes found in the X-ray structures of 
hDKK1C2-hLRP6PD3 (PDB code: 3S2K and 3S8V) 
were similar to our predicted complex model (Cα 
RMS deviation ≈4Å).  Judging from the accordance 
with the experimental results,  we concluded that our 
approach can provide an appropriate prediction for the 
complex structures and aﬃnity proﬁles.
　 In the dynamic structure of the hDKK1C2-hLR-
P6PD1 complex model,  the hydrogen bonds involved 
in the stabilized regions in hDKK1C2 (C195-H204,  
S207-R225 and R236-Q253) signiﬁcantly contribute 
to the aﬃnity of the complex.  One of the stabilized 
regions,  C195-H204,  is responsible for 5 stable 
hydrogen bonds with LRP6PD1.  In addition,  S207- 
R225 and R236-Q253 involve nine and 6 hydrogen 
bonds,  respectively.  Based on the occurrence of 
HBN,  the contact of FL1 in hDKK1C2 is a signiﬁcant 
factor underlying the physical recognition of hLRP6.  
Additionally,  hydrogen bonds between Ser192OG in 
hDKK1C2 and Ser243OG in hLRP6PD1 were 
observed in the MD simulation of the complex model 
(Table 4A).  As described in the previous section,  in 
the complex model by PPD,  the hydroxyl group of 
Ser243 interacted with the main-chain nitrogen atom 
of the other residue (Cys201).  The change in the 
hydrogen bond network resulted from structural 
reﬁnement by the MD simulation.  Chen et al.  reported 
that a mDKK1 mutant,  H267E,  attenuates the binding 
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Table 5　 Aﬃnity proﬁle of mutant models of C2 hDKK3 (see text 
for details) for PD models of hLRP5.  The values are in kcal/mol.
ΔGbinding＊ hDKK3C2Δ hDKK3C2ΔP258G
hLRP5PD1 －40.57 －41.43
hLRP5PD2 －39.75 －48.90
hLRP5PD3 －28.89 －28.07
hLRP5PD4 －32.52 －44.58
The values are in kcal/mol.
aﬃnity for mLRP6 [24].  In hDKK1,  the sequence of 
amino acid residues corresponds to H261.  In our MD 
simulation of hDKK1C2-hLRP6PD1 complex model,  
a weak hydrogen bond between H261NE2 in hDKK1C2 
and E115OE1 in hLRP6PD1 was observed (Table 
4A).  Hence,  the results of the simulation are also 
consistent with LRP6-binding deﬁciency in the H267E 
mutant of mDKK1.
　 It was found from the MD simulation of complex 
models of hDKK1C2-hLRP5PD1 and hDKK1C2-
hLRP6PD1 that R203,  K222,  K226 and Q235 in 
hDKK1C2 produce stable intermolecular hydrogen 
bonds in both complex models and that 3 residues 
(K222,  K226 and Q235) are part of the FL1 region.  
Therefore,  we can conclude that FL1 is the most 
important factor for the receptor recognition.  G171V 
located on hLRP5PD1 is genetically linked to high 
bone-mass [30,  36].  Therefore,  G171 is considered 
to be involved in recognition of the DKK protein.  In 
the MD simulation,  a hydrogen bond was detected 
between the backbone oxygen atom of G171 and the 
guanidinium group of R203 in hDKK1C2 (Table 3B).  
Mutation of glycine to valine may disturb the approach 
of the side chain of R203 due to its hydrophobicity.  
Hence,  it is thought that the G171V mutation on 
hLRP5 reduces the aﬃnity for hDKK1 due to loss of 
the hydrogen bond with R203 in hDKK1C2.  Since the 
ﬁrst report on G171 mutation,  several mutations have 
been reported to be related to osteogenic disorders,  
including D111Y,  G171R,  A214T/V,  A242T and 
T253I [37].  Furthermore,  A65V,  S127V,  L200V 
and M282V have also been reported to be potential 
disease-causing mutations because they are positioned 
at equivalent sites of G171 in each blade-propeller of 
LRP5PD1,  and all of the mutant proteins have no 
WNT signaling activity due to a lack of aﬃnity for 
DKK proteins [34].  At least in our MD simulation,  
however,  direct interactions between the residues at 
the mutation sites described above and the residues in 
hDKK1C2 models were not found throughout the 
entire duration of MD simulation.  Therefore,  these 
mutants may have impaired function due to diﬀerent 
factors,  such as irrecoverable failure in the protein 
folding or a drastic change in the whole structure of 
the ligand binding site.
　 Based on the results of molecular simulation and a 
comparison with the results of experimental studies,  
we propose a novel hypothesis wherein the conserved 
7-amino-acid insertion and P258 in DKK3 coopera-
tively lead to the lower binding aﬃnity for LRP5/6.  
This means that the 7-amino-acid insertion and the 
substitution to proline may be evolutionally critical for 
the birth of DKK3 from the ancestral gene of the 
DKK family.  The unique sequence in DKK3 may be a 
driving force for the acquisition of intrinsic biological 
functions,  such as tumoricidal eﬀects and anti-tumor 
immune response [58].  It remains an open question 
why the insertion sequence (LDLITWE) is perfectly 
conserved between human and mouse DKK3.  According 
to the orthologous gene database,  Evola [59],  the 
conservation is not only observed in humans and mice 
but also in Pan troglodytes, Macaca mulatta, Rattus nor-
vegicus, Canis familiaris, Equus caballus, Bos taurus, and 
Monodelphis domestica. Interestingly,  the DKK3 genes 
among more remotely related species encode slightly 
changed variants,  such as Gallus gallus (LNLITWE),  
Danio rerio (MEVLLWE),  Oryzias latipes (MDMLAWD) 
and Takifugu rubripes (MDMLAWD).  Comparative 
analysis of the species indicates the presence of a 
sequence motif of 7 amino acids as follows.  The motif 
starts with methionine or leucine.  The second position 
is of acid type (D/E),  the fourth position is leucine or 
isoleucine,  the sixth is always tryptophan,  and the 
seventh is an acidic residue again.  We believe that the 
conserved residues are not only responsible for the 
inaccessibility to LRP5/6 but also have an important 
role for the speciﬁc recognition by a canonical recep-
tor for DKK3.
　 The biological function of the inserted sequence of 
DKK3 has not been reported yet.  So far,  three 
potential candidates for DKK3 receptors have been 
independently reported.  One of the candidates is 
β-TrCP1 (β-transduction repeat-containing protein),  
which is involved in the ubiquitin-mediated protein 
degradation pathway [60].  This receptor candidate 
was detected by yeast-two-hybrid (Y2H) screening for 
a DKK3 receptor.  It should be noted that β-TrCP1 is 
usually localized in the cytoplasm,  while the gene 
product of DKK3 is secreted into the extracellular 
space.  Interestingly,  it was experimentally conﬁrmed 
that the DKK3 protein is expressed in the cytoplasm.  
The DKK3 in the cytoplasm can be translated from an 
alternative splicing mRNA isoform that lacks the cod-
ing region of signal sequences for destination to the 
endoplasmic reticulum.  In fact,  an mRNA variant of 
the DKK3 that lacks the signal sequence has been 
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cloned (AK092979) [61].  The variant form of DKK3 
protein is spatially localized in the cytoplasm and 
interacts with β-TrCP1.  X-ray crystallographic 
analysis revealed that β-TrCP1 has a β-propeller 
domain (PDB code: 1P22) [62].  From the structural 
analysis,  it can be hypothesized that cytoplasmic DKK3 
interacts with the β-propeller domain by the C2 
domain,  because DKK1/2/4 also targets a propeller-
shaped structure.  However,  this hypothesis is only 
based on structural analogy.  Hence,  further analysis 
is required.  Kremen-1/2 have been reported to be 
novel binding partners of DKK3 [63].  Kremen-1/2 
are secreted-type proteins that are involved in WNT 
signaling,  and therefore are potential candidates for 
the binding partner of the secreted form of DKK3.  
Unfortunately,  three-dimensional structures of the 
Kremen proteins have not yet been clariﬁed.  When 
structural information on the receptor becomes avail-
able,  it will be very helpful to examine the physico-
chemical interaction with DKK3.  Finally,  the use of 
a combination of Y2H and a mammalian two-hybrid 
system revealed Tctex-1 as a potential candidate for 
the receptor for hDKK3 [64].  The experimental 
results thus indicate a variety of functions of DKK3.
　 In this study,  PPD simulation was performed by 
ZDOCK and aﬃnity estimation was executed by the 
RDOCK/CHARMM system.  It should be noted that 
ZDOCK employs a rigid docking algorithm.  Also,  
there is currently no optimal scoring function that 
correctly predicts the experimentally determined 
aﬃnities [65].  In a future study,  the prediction 
strategy should be improved by combined use of ﬂex-
ible docking and a more eﬃcient scoring function.
　 In conclusion,  The reason why DKK3 does not 
interact with LRP5/6 was clariﬁed by comparing 
structural properties of complex models consisting of 
high-aﬃnity ligands and receptors.  We found from the 
simulation that the aﬃnity between C2 and PD 
domains strongly depends on interaction with the FL1 
region in the C2 domain.  However,  in DKK3,  longer 
FL1 including a unique inserted sequence (LDLITWE) 
disturbs proper interaction with PD domains.  The 
conformational restriction of FL1 caused by P258 is 
also thought to inﬂuence the aﬃnity.  The sequences 
and structural property unique to the C2 domain found 
in DKK3 might be a key for identifying its receptor.
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